Since TNBC has been reported to harbor a high probability of BRCA1 deficiency and a homologous recombination defect (HRD), we hypothesized that STC1 has an important role in DNA repair and can be used as a biomarker for DNA damage-inducing agents in breast cancer. Here, STC1 is linked to breast carcinoma.